Christopher Bowden
Director/Board Member at Cedilla Therapeutics, Inc.
Christopher Bowden active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 2021-04-20 | - |
Career history of Christopher Bowden
Former positions of Christopher Bowden
| Companies | Position | Start | End |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 2019-10-07 | 2023-03-29 |
| Independent Dir/Board Member | 2019-10-07 | 2023-03-29 | |
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2014-05-13 | 2021-08-31 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 2017-08-09 | 2020-09-30 |
| Independent Dir/Board Member | 2017-08-09 | 2020-09-30 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2005-12-31 | 2014-04-30 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2005-12-31 | 2013-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2002-12-31 | 2005-12-31 |
Training of Christopher Bowden
| Drexel University College of Medicine | Doctorate Degree |
| Lake Forest College | Undergraduate Degree |
Statistics
International
| United States | 9 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Bowden
- Experience